Company Overview and News

11
Idera Pharmaceuticals Announces Appointment of Howard Pien to its Board of Directors

2018-09-18 globenewswire
EXTON, Pa., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, tilsotolimod, for the treatment of cancer, today announced that Howard Pien joined its Board of Directors, effective September 18, 2018.
ABT SAGE INVVY IDRAW JUNO IDRA VNDA IZQVF ABT

 
Vanda: A Grower Operating At An Inflection

2018-09-17 seekingalpha
Vanda is a highly promising growth bioscience that recently banked a net profit, thus signaling its entry into an aggressive growth phase.
VNDA

 
VNDA / Vanda Pharmaceuticals, Inc. 8-K (Current Report)

2018-08-14 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
VNDA

9
The Zacks Analyst Blog Highlights: Goldman Sachs, JP Morgan Chase and Morgan Stanley

2018-08-07 zacks
Chicago, IL – August 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Goldman Sachs (GS - Free Report) , JP Morgan Chase (JPM - Free Report) and Morgan Stanley (MS - Free Report) .
GIII ADBE ECHO RCKY AMT MTN VNDA MLNX ARW CVLT MS ADM HUBG HUBOF GTLS

12
Zacks.com highlights: Steel Dynamics, Sprouts Farmers Market, Nucor, Big Lots and WellCare Health Plans

2018-08-07 zacks
Chicago, IL – August 7, 2018 - Stocks in this week’s article include: Steel Dynamics, Inc. (STLD - Free Report) , Sprouts Farmers Market, Inc. (SFM - Free Report) , Nucor Corp. (NUE - Free Report) , Big Lots, Inc. (BIG - Free Report) and WellCare Health Plans, Inc. (WCG - Free Report) .
STLD WCG BIG GIII NUE ADBE ECHO RCKY SFM AMT MTN VNDA MLNX ARW CVLT ADM HUBG HUBOF GTLS

9
The Zacks Analyst Blog Highlights: Harris, Huntington Ingalls Industries, Spirit Aerosystems, L3 Technologies, Raytheon and Leidos Holdings

2018-08-07 zacks
Chicago, IL – August 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Harris Corporation (HRS - Free Report) , Huntington Ingalls Industries, Inc. (HII - Free Report) , Spirit Aerosystems Inc. (SPR - Free Report) , L3 Technologies, Inc.
LMT GD LDOS GIII ADBE ECHO RCKY NOC HII AMT MTN VNDA MLNX ARW RTN CVLT HRS ADM HUBG HUBOF GTLS

12
The Zacks Analyst Blog Highlights: Disney, Twenty-First Century Fox, Comcast, Netflix, Amazon and Apple

2018-08-07 zacks
Chicago, IL – August 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Disney (DIS - Free Report) , Twenty-First Century Fox (FOXA - Free Report) , Comcast (CMCSA - Free Report) , Netflix (NFLX - Free Report) , Amazon (AMZN - Free Report) and Apple (AAPL - Free Report) .
FOX CMCSA NFLX GIII ADBE ECHO RCKY AMT MTN VNDA MLNX ARW AAPL CVLT ADM FOXA HUBG HUBOF GTLS

10
Zacks.com highlights: ArcBest, Big Lots, Arrow Electronics, ON Semiconductor and Meritage Homes

2018-08-07 zacks
Chicago, IL – August 7, 2018 - Stocks in this week’s article include: ArcBest Corporation (ARCB - Free Report) , Big Lots, Inc. (BIG - Free Report) , Arrow Electronics, Inc. (ARW - Free Report) , ON Semiconductor Corporation (ON - Free Report) and Meritage Homes Corporation (MTH - Free Report) .
ARCB BIG ON GIII ADBE ECHO RCKY MTH MTN AMT ARW MLNX VNDA CVLT ADM HUBG HUBOF GTLS

48
Amazon, Ford Motor and Etsy highlighted as Zacks Bull and Bear of the Day

2018-08-07 zacks - 1
Chicago, IL – August 7, 2018 – Zacks Equity Research highlights Amazon.com, Inc. (AMZN - Free Report) as the Bull of the Day, Ford Motor Company (F - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Etsy (ETSY - Free Report) .
GIII ADBE ECHO RCKY AMZN AMT MTN VNDA MLNX ARW CVLT ADM HUBG HUBOF ETSY GTLS

10
The Zacks Analyst Blog Highlights: SPS Commerce, BJ's Restaurants, Altra Industrial Motion, BG Staffing and Kforce

2018-08-07 zacks
Chicago, IL – August 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include SPS Commerce, Inc. (SPSC - Free Report) , BJ's Restaurants, Inc. (BJRI - Free Report) , Altra Industrial Motion Corp. (AIMC - Free Report) , BG Staffing, Inc.
BGSF GIII ADBE ECHO RCKY SPSC KFRC AMT MTN AIMC BJRI VNDA MLNX ARW CVLT ADM HUBG HUBOF GTLS

31
The Zacks Analyst Blog Highlights: Caterpillar, BHP Billiton and Celgene

2018-08-07 zacks
Chicago, IL – August 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Caterpillar (CAT - Free Report) , BHP Billiton (BHP - Free Report) and Celgene (CELG - Free Report) .
BLT CAT GIII ADBE AMT CELG HUBG DIS BHPBF ECHO RCKY BHP MTN VNDA MLNX ARW BBL BHP CVLT ADM BHPLF HUBOF GTLS

13
Pacira (PCRX) Q2 Earnings and Revenues Surpass Estimates

2018-08-06 zacks
Pacira Pharmaceuticals, Inc. (PCRX - Free Report) reported second-quarter 2018 earnings of 24 cents per share, surpassing the Zacks Consensus Estimate of 9 cents and the loss of 11 cents incurred a year ago.
EGRX JNJ PCRX VNDA HZNP BPL

13
The Zacks Analyst Blog Highlights: Pfizer, Bristol-Myers, Sanofi, Glaxo and Novartis

2018-08-06 zacks
Chicago, IL – August 6, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Pfizer (PFE - Free Report) , Bristol-Myers (BMY - Free Report) , Sanofi (SNY - Free Report) , Glaxo (GSK - Free Report) and Novartis (NVS - Free Report) .
GIII BGSF SNY ADBE ECHO RCKY MTN VNDA MLNX ARW NVS CVLT ADM PFE HUBG HUBOF

9
Zacks.com highlights: G-III Apparel Group, Rocky Brands, Vail Resorts, Vanda Pharmaceuticals and IntriCon

2018-08-06 zacks
Chicago, IL – August 6, 2018 - Stocks in this week’s article include: G-III Apparel Group, Ltd. (GIII - Free Report) , Rocky Brands, Inc. (RCKY - Free Report) , Vail Resorts, Inc. (MTN - Free Report) , Vanda Pharmaceuticals Inc. (VNDA - Free Report) and IntriCon Corp. (IIN - Free Report) .
IIN GIII BGSF ADBE RCKY ECHO MTN VNDA MLNX ARW CVLT ADM HUBG HUBOF

11
Zacks.com highlights: Mellanox Technologies, Fortinet, Commvault Systems and Adobe Systems

2018-08-06 zacks - 1
Chicago, IL – August 6, 2018 - Stocks in this week’s article include: Mellanox Technologies Ltd. (MLNX - Free Report) , Fortinet Inc. (FTNT - Free Report) , Commvault Systems, Inc. (CVLT - Free Report) and Adobe Systems Inc. (ADBE - Free Report) .
GIII BGSF ADBE ECHO RCKY MTN MLNX VNDA ARW CVLT ADM HUBG HUBOF FTNT

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 921659108